Filter:
Co-authored by Alpha-1 Foundation Board of Director James Stoller, MD, MS CLEVELAND — Tips to avoid becoming infected with COVID-19 […]
March 26, 2020 Early this morning, the Senate passed a $2 trillion COVID-19 relief bill. The Bill (S. 3548) is […]
Read More… from CARES ACT Bill (S.3548) passed by The Senate
Barcelona, March 25, 2020 – Grifols today announces that it has entered into a formal collaboration with the United States […]
Because of COVID-19’s impacts on the lungs, the U.S. Alpha-1 Foundation has provided detailed, specific guidance for patients who have alpha […]
Read More… from Coronavirus: Alpha 1 Group Gives Specific Guidance for Patients
This coalition waiver request adds three additional options for physicians and home health agencies as they endeavor to keep those with […]
STATEMENT UPDATED: March 18, 2020 It is our commitment to provide you with updated guidelines on COVID-19, please find the […]
Read More… from WEDNESDAY, MARCH 18 COVID-19 Update from the Alpha-1 Foundation & AlphaNet
Shortly after the FDA granted an Emergency Use Authorization to its first commercially developed coronavirus test—developed by Roche for use […]
For many immunocompromised people, social distancing isn’t a new endeavor. Alpha-1 Antitrypsin Deficiency is sometimes called an “invisible disability”. This […]
STATEMENT UPDATED: March 12, 2020 Please note, this statement is specific to the United States. If you are an individual […]
Read More… from THURSDAY, MARCH 12 COVID-19 Update from the Alpha-1 Foundation & AlphaNet
STATEMENT UPDATED: March 9, 2020 Please note, this statement is specific to the United States. If you are an individual […]
Read More… from COVID-19 Update from the Alpha-1 Foundation & AlphaNet
